ATE228506T1 - Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz - Google Patents

Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz

Info

Publication number
ATE228506T1
ATE228506T1 AT98934892T AT98934892T ATE228506T1 AT E228506 T1 ATE228506 T1 AT E228506T1 AT 98934892 T AT98934892 T AT 98934892T AT 98934892 T AT98934892 T AT 98934892T AT E228506 T1 ATE228506 T1 AT E228506T1
Authority
AT
Austria
Prior art keywords
synthesis
inhibitors
drug resistance
multiple drug
acridine derivatives
Prior art date
Application number
AT98934892T
Other languages
English (en)
Inventor
Matthew Jude Sharp
Catherine J Mader
Calum Strachan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE228506T1 publication Critical patent/ATE228506T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT98934892T 1997-05-23 1998-05-22 Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz ATE228506T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710612.4A GB9710612D0 (en) 1997-05-23 1997-05-23 Synthesis of acridine derivatives
PCT/EP1998/002991 WO1998052923A1 (en) 1997-05-23 1998-05-22 Synthesis of acridine derivative multidrug-resistant inhibitors

Publications (1)

Publication Number Publication Date
ATE228506T1 true ATE228506T1 (de) 2002-12-15

Family

ID=10812906

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934892T ATE228506T1 (de) 1997-05-23 1998-05-22 Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz

Country Status (18)

Country Link
US (1) US6248891B1 (de)
EP (1) EP0983246B1 (de)
JP (1) JP4390861B2 (de)
KR (1) KR100536155B1 (de)
CN (1) CN1178918C (de)
AT (1) ATE228506T1 (de)
AU (1) AU744402B2 (de)
BR (1) BR9809143A (de)
CA (1) CA2289492C (de)
DE (1) DE69809733T2 (de)
DK (1) DK0983246T3 (de)
ES (1) ES2187984T3 (de)
GB (1) GB9710612D0 (de)
HU (1) HUP0002083A3 (de)
IL (1) IL132593A (de)
PL (1) PL190109B1 (de)
PT (1) PT983246E (de)
WO (1) WO1998052923A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
WO2000021951A1 (en) 1998-10-08 2000-04-20 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
DE60030283T2 (de) * 1999-05-17 2007-09-20 Cancer Research Ventures Ltd. Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
SI21507A (sl) 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
US7829578B1 (en) 2005-12-12 2010-11-09 Oregon Health & Science University Aromatic ketones and uses thereof
US8592447B2 (en) 2006-11-13 2013-11-26 Oregon Health & Science University Acridone compounds
US8598354B2 (en) 2008-12-05 2013-12-03 University Of South Florida Compounds having antiparasitic or anti-infectious activity
CA3093985A1 (en) * 2018-03-21 2019-09-26 Izumi Technology, Llc Deuterated analogs of elacridar

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100220538B1 (ko) * 1991-01-11 1999-09-15 뮈쉘 쥐르밀 아크리딘 유도체
CZ104197A3 (en) * 1994-10-05 1997-09-17 Glaxo Wellcome Inc Pharmaceutical preparation

Also Published As

Publication number Publication date
CN1178918C (zh) 2004-12-08
DE69809733T2 (de) 2003-09-18
IL132593A0 (en) 2001-03-19
IL132593A (en) 2004-07-25
HUP0002083A3 (en) 2002-03-28
PL190109B1 (pl) 2005-10-31
CA2289492C (en) 2009-03-24
BR9809143A (pt) 2000-08-01
DE69809733D1 (de) 2003-01-09
HK1023995A1 (en) 2000-09-29
WO1998052923A1 (en) 1998-11-26
KR20010012817A (ko) 2001-02-26
EP0983246A1 (de) 2000-03-08
PL336937A1 (en) 2000-07-17
KR100536155B1 (ko) 2005-12-14
US6248891B1 (en) 2001-06-19
ES2187984T3 (es) 2003-06-16
JP4390861B2 (ja) 2009-12-24
CA2289492A1 (en) 1998-11-26
GB9710612D0 (en) 1997-07-16
JP2002502371A (ja) 2002-01-22
PT983246E (pt) 2003-04-30
HUP0002083A2 (hu) 2001-04-28
AU744402B2 (en) 2002-02-21
AU8434498A (en) 1998-12-11
EP0983246B1 (de) 2002-11-27
CN1255918A (zh) 2000-06-07
DK0983246T3 (da) 2003-03-24

Similar Documents

Publication Publication Date Title
DE60004060D1 (de) Eletrolytische synthese von peressigsäure
ATE228506T1 (de) Synthese von acridinderivaten als inhibitoren von multipler medikamentenresistenz
NO971684D0 (no) Nye benzoxazoler
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
DE69840519D1 (de) Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor
MXPA03011681A (es) Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular.
ATE311363T1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
TR200201638T2 (tr) Yeni imidazo[1,3,5]triazinonlar ve kullanımları
IL148932A0 (en) INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
HU0302788D0 (en) New compounds
ES2188983T3 (es) Nuevas benzofuran-4-carboxamidas.
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
TR199901761T2 (xx) IL-8 resept�r antagonistleri.
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
DE69702182D1 (de) Alkylierte styrole als prodrugs zu cox-2-inhibitoren
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
DE69911603D1 (de) Synthese von 5- oder 8-bromoisoquinolin derivaten
ATE198323T1 (de) Diphenylstibene als prodrugs zu cox-2-inhibitoren
YU59100A (sh) Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
ATE284382T1 (de) Hydroxamsäurederivat als inhibitor der produktion von löslichem menschlichem cd23
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0983246

Country of ref document: EP

REN Ceased due to non-payment of the annual fee